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Two clinical isolates of viridans streptococci (VS), with different degrees of 
susceptibility to optochin (OPT) i.e., the fully OPT-susceptible (OptS) VS 1162/99 (MIC 
equal to that of Streptococcus pneumoniae, 0.75 g/ml) and the intermediate OptS VS 
1174/97 (MIC of 6 g/ml) were studied. Besides being OptS, they showed typical VS 
characteristics such as bile insolubility, lack of reaction with pneumococcal capsular 
antibodies and lack of hybridization with rRNA (AccuProbe), lytA, and pnl specific 
pneumococcal probes. However, these VS OptS strains, and VS type strains hybridized 
with ant, a gene not present in S. pneumoniae. A detailed characterization of the genes 
encoding the 16S rRNA and SodA classified isolates 1162/99 and 1174/97 as S. mitis. 
Analysis of the atpCAB region that encodes the c, a and b subunits of the F0F1 H+ -
ATPase, the target of optochin, revealed high similarity  between S. mitis  1162/99 and S. 
pneumoniae in atpC, atpA and the N-terminus of atpB. Moreover, amino acid identity 
between S. mitis  1174/97 and S. pneumoniae was found in -helix 5 of the a subunit. The 
organization of the chromosomal region containing the atp-operon of the two OptS VS 
and VS type strains was spr1284-atpC, spr1284 being located at 296-556-bp from atpC 
whereas in S. pneumoniae this distance is longer than 68 kb. In addition, gene order in S. 
pneumoniae was IS1239-74 bp-atpC. Results suggested that the full OPT-susceptibility of 
S. mitis 1162/99 is due to the acquisition of atpC, atpA and part of atpB from S. 
pneumoniae and that the intermediate OPT-susceptibility of S. mitis 1174/97 correlates 
with the amino acid composition of its a subunit. 
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Streptococcus pneumoniae (the pneumococcus) remains a major etiological agent of 
community-acquired pneumonia, meningitis and acute otitis media (6). Four phenotypic 
characteristics are classically used in the diagnostic laboratory for the identification of the 
pneumococcus: colony morphology on blood agar plates, optochin (OPT) susceptibility, bile 
solubility, and immunological reaction with type-specific antisera (23). Although their colony 
morphology can be very similar, the alpha-hemolytic oral streptococci (known as viridans 
streptococci, VS), notably Streptococcus mitis and Streptococcus oralis, are classically OPT-
resistant (OptR) and bile insoluble (23).  
Genetic and biochemical evidences support that the typical OPT-susceptibility of the 
pneumococcus resides in the characteristics of the F0 complex of its F0F1 H
+-ATPase, an 
enzyme that is essential for the viability of this organism (10). The primary roles of this 
enzyme are to create a proton gradient with the energy provided by ATP hydrolysis and to 
maintain the intracellular pH via proton extrusion (25) as in other related bacteria (18). 
However, in bacteria having a respiratory chain, the role of the F0F1 H
+-ATPase is the 
synthesis of ATP from the proton gradient of the respiratory chain. Hydrolysis of ATP on the 
cytoplasmic F1 sector (formed by the , , , , and  subunits) drives proton transport 
through the F0 cytoplasmic membrane sector (formed by the a, b, and c subunits) by long-
range conformational changes. Conformational changes in the F1  subunits drive hydrolysis 
of ATP (1), which generates rotation of the attached  and  subunits. This rotation, in turn, 
causes the rotation of an oligomeric ring of c subunits (33, 38) and the pumping of protons 
across the membrane through F0. The activity of the F0F1 ATPase of S. pneumoniae is pH-
inducible and is regulated at the level of initiation of transcription (25). 
Pneumococcal strains resistant to amino-alcohol antimalarial drugs such as OPT, 
quinine (QIN), and mefloquine (MFL) have point mutations that change amino acid residues 
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located in one of the two transmembrane -helices of the c subunit or in one of the two last -
helices of the a subunit (9, 24, 28, 31) suggesting that those -helices of the c and a subunits 
interact and that the mutated residues are important for the structure of the F0 complex and 
proton translocation. Although OPT was used at the beginning of the 20th century for the 
treatment of pneumococcal infections (26), its use is nowadays restricted to diagnostic 
purposes due to its high toxicity. However, new less toxic, mefloquine-related compounds 
that also target the F0 complex of the F0F1 ATPase (24) have been synthesized (22). 
Although several S. pneumoniae OptR isolates have been reported (21, 27, 30, 31, 40), 
to the best of our knowledge, there is a single report of VS with an OptS phenotype (5). In this 
work we describe the genetic characterization of two OptS VS clinical isolates. 
 
MATERIALS AND METHODS 
 Antimicrobial susceptibility testing. OPT sensitivity tests were performed by placing 5-
g OPT disks (Becton Dickinson Microbiology Systems) onto Mueller-Hinton agar plates 
(Difco) supplemented with 5% defibrinated sheep blood streaked with the bacteria being 
tested. After overnight incubation at 37ºC in a CO2 atmosphere, inhibition zones around the 
disk were measured, and isolates with zones 14 mm were considered as sensitive. MICs 
were determined by the microdilution method, using cation-adjusted Mueller-Hinton broth 
supplemented with 2.5% lysed horse blood as recommended by the National Committee for 
Clinical Laboratory Standards (29). The inoculum was prepared by suspension of several 
colonies from an overnight blood agar culture in Mueller-Hinton broth and adjusting the 
turbidity to the 0.5 McFarland standard (ca. 108 CFU/ml). The suspension was further diluted 
to provide a final bacterial concentration of 104 CFU/ml in each well of the microdilution 
trays. Plates were covered with plastic tapes and incubated in ambient atmosphere at 37ºC for 
20-24 h. MIC was defined as the lowest concentration of drug that inhibited visible growth. S. 
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pneumoniae ATCC strains 6303 and 49619, S. mitis NCTC 12261T (SmiT), and S. oralis 
NCTC 11427T (SorT) and ATCC 10557 were used for the quality control. OPT and QIN  were 
purchased from Sigma Chemical, St. Louis, Mo. MFL  (Ro 21-5998-000) was provided by 
Roche Laboratories, Basel, Switzerland. 
 PCR amplification and DNA sequence determination. Chromosomal DNA was 
prepared as described previously (12) from the laboratory S. pneumoniae R6 strain, SmiT, 
SorT, and the clinical isolates. Gel electrophoresis of PCR products was carried out in agarose 
gels as described previously (35). PCR amplifications were performed using 0.51 units of 
Thermus thermophilus thermostable DNA polymerase (Biotools), 0.1 g of chromosomal 
DNA, 0.41 M (each) of the synthetic oligonucleotide primers, 0.2 mM of each dNTP in a 
final volume of 50 l, in the buffer recommended by the manufacturers. Amplification was 
achieved with an initial cycle of 1 min denaturation at 94ºC, 2530 cycles of 3060 seconds 
of denaturation at 94ºC, 90 seconds of annealing at 55ºC, and 12 min of polymerase 
extension at 72ºC, with a final 8 min extension at 72ºC and slow cooling at 4ºC. 
Oligonucleotides used in PCR amplifications are described in Table 1. To amplify the atpC 
and atpA genes, two pairs of oligonucleotides were used: atp660 (28) and atpB56, or atpWO 
and atpB56 (24). For the sequencing of the atpCA regions of the various strains used, several 
internal oligonucleotides were synthesized. Oligonucleotides atpc18RSpn, atpc18RSmi, 
atpc18RSor and UPatp3 were used for sequencing of the atpC upstream regions. We also 
used primers 16SDNAF1 and 16SDNAR1 to amplify the 16sRNA genes, and these same 
primers and the internal oligonucleotides 16SDNAF2 and 16SDNAR2 for sequencing. 
Primers SODUP and SODDOWN were used to amplify and sequence the sodA gene (20). 
PCR products were purified using MicroSpinTM S400 HR columns (Amersham-Pharmacia-
Biotech) and sequenced on both strands with an Applied Biosystems Prism 377 DNA 
sequencer. 
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 Southern blot identification of strains and determination of the genetic structures of 
the chromosomal regions located upstream of atpC. For detection of the ribosomal RNA 
genes, the Accuprobe S. pneumoniae Culture Identification test (Gen-Probe, San Diego, 
Calif.) was used according to the manufacturer’s instructions with four colonies from an 
overnight culture on 5 % blood agar. lytA and pnl DNA probes were prepared as described 
(11). A 798-bp probe derived from S. pneumoniae 3870 (11), a strain with a recombinational 
origin that had acquired the ant gene from a VS, encoding amino acid residue positions 26 to 
290 of the 290-amino-acid-residue Ant protein (3) was obtained by PCR amplification with 
oligonucleotides antUP and antDOWN. The 936-bp spr1284 probe was obtained by 
amplification of S. pneumoniae R6 with oligonucleotides pepti101 and pepti413R. The 
AtpCA probe was obtained by amplification of S. pneumoniae R6 with oligonucleotides 
atpWO and atpA107R. DNA inserts and PCR fragments were labeled with the Phototope-Star 
Detection Kit (New England Biolabs). Southern blot and hybridization followed the 
manufacturer’s instructions. 
 Nucleotide sequence accession numbers. The sequences of the atpCAB genes reported 
here have been deposited in GenBank under accession numbers AY172982 (VS isolate 
1162/99), AY172983 (VS isolate 1174/97), AY172984 (S. mitis NCTC 12261), AY172985 
(S. pneumoniae ATCC 6303) and AY172986 (S. pneumoniae ATCC 49619). The sodA 
fragments have been assigned accession numbers AY314979 and AY314980. 
 
RESULTS 
Isolation and identification at the species level of strains 1162/99 and 1174/97. 
Clinical isolates are received at the Pneumococcal Reference Laboratory, Madrid, Spain, for 
typing purposes and antibiotic resistance surveillance. Isolates are routinely confirmed to be 
S. pneumoniae by colony morphology on blood agar, OPT-susceptibility, and sodium 
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deoxycholate solubility. Two of these isolates, which were isolated from valuable sputum 
samples from patients with pneumonia and identified at the hospital laboratory as S. 
pneumoniae for being OptS (optochin disk inhibition zones of 14 mm for isolate 1174/97 and 
20 mm for isolate 1162/99), drew our attention since they were insoluble in sodium 
deoxycholate. In addition, their DNAs did not show hybridization with the pnl, lytA and  
ribosomal DNA (AccuProbe) pneumococcal-specific probes (data not shown). On the other 
hand, phenotypic characterization of the OptS isolates 1174/97 and 1162/99 by the API 32 
Strep system classified them as S. oralis.  
In a recent work carried out in our laboratory we detected an open reading frame, ant 
that is not present in S. pneumoniae strains but that it is found in S. mitis and S. oralis (3). A 
probe containing this gene was used in Southern blot experiments using chromosomal DNAs 
from isolates 1162/99 and 1174/99. Both OptS VS isolates, SmiT and SorT showed 
hybridization with the ant probe, whereas S. pneumoniae R6 did not (Fig. 1A). These 
experiments suggested that, in spite of being OptS, isolates 1162/99 and 1174/97 were not 
pneumococcal strains. To determine the phylogenetic position of strains 1162/99 and 1174/97 
among VS, we amplified and sequenced a 1,138-nt internal fragment of the genes encoding 
their 16S rRNA (data not shown). Sequence comparison revealed more than 99% identity 
with the 16S rRNA genes of S. pneumoniae, S. mitis, and S. oralis, whereas lower similarities 
(98.2 to 97.6) were found with other species (Streptococcus gordonii, Streptococcus sanguis 
and Streptococcus parasanguis) of the mitis group, indicating that isolates 1162/99 and 
1174/97 belong to the mitis group of VS (19). Recent works (20, 32) have shown that 
sequence analysis of sodA is a faithful method for identification of species within the mitis 
group. The sequences of an internal sodA portion (366 bp) of the 1162/99 and 1174/97 strains 
were determined and compared with those of the laboratory R6 strain, S. pneumoniae 
NCTC7465T, SmiT, SorT, S. gordonii ATCC10558T, S. sanguis ATCC10556T and S. 
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parasanguis ATCC15910T. The sodA sequences of 1162/99 and 1174/97 were very similar 
(98.1 % identical) and showed high similarities (higher than 96%) with those of SmiT and S. 
pneumoniae strains (Fig. 1B). Lower similarities were found with other species of the S. mitis 
group: lower than 93 %, 83%, 82% and 88% with SorT, S. gordonii, S. sanguis and S. 
parasanguis, respectively. 
Taken together, these results classified the 1162/99 and 1174/97 isolates as S. mitis. 
Susceptibilities of strains to amino alcohol antimalarial drugs and sequence of the 
atpC and atpA genes. The characterization of pneumococcal strains carrying point mutations 
in atpC or atpA (24) provided a criteria to categorize the susceptibility to OPT, QIN and 
MFL. Strains were considered susceptible when their OPT MICs were 1.5 g/ml, their QIN 
MICs were 50 g/ml, or their MFL MICs were 1.25 g/ml. MICs for intermediate 
susceptible strains being in the 3 to 6 g/ml OPT range, in the 100 to 200 g/ml QIN range, 
and in the 0.31 to 0.62 g/ml MFL range. Strains were considered resistant when their OPT 
MICs were 6 g/ml, their QIN MICs were 200 g/ml, or their MFL MICs were 0.62 
g/ml. By these criteria, isolate 1162/99 was susceptible to OPT and QIN, and intermediate 
susceptible to MFL (Table 2 ). However, isolate 1174/97 showed intermediate susceptibility 
to OPT and resistance to QIN and MFL (Table 2). Since the mutations involved in OPT 
resistance map in the atpC and atpA genes, the nucleotide sequences of these genes from the 
two OptS VS clinical isolates, together with that of SmiT, S. pneumoniae ATCC 6303 and S. 
pneumoniae ATCC 49619 were determined and compared to the published sequences of S. 
pneumoniae R6 and SorT (9). PCR fragments of about 1 kb were obtained by amplification of 
S. pneumoniae ATCC 6303 and S. pneumoniae ATCC 49619 strains (by using 
oligonucleotides atp660 and atpB56) and SmiT, S. mitis 1162/99 and S. mitis 1174/97 (by 
using oligonucleotides atpWO and atpB56). Those fragments were sequenced with the same 
primers used in the PCR amplifications as well as with internal primers. The nucleotide 
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sequence of the atpC and atpA genes from isolate 1162/99 showed almost complete identity 
with that of S. pneumoniae strains (Fig. 2A). However, the nucleotide sequence from isolate 
1174/97 showed higher identities with that of SmiT (83.07 %) and SorT (80.99%) than with S. 
pneumoniae (79.51%). These nucleotide changes yielded, when compared with S. 
pneumoniae R6, a single amino acid change (cL6F) in the c subunit of isolate 1162/99, 8 
changes in isolate 1174/97 (Fig. 2B), but no changes in S. pneumoniae ATCC 6303 and S. 
pneumoniae ATCC 49619. Two changes in the a subunit were observed in S. pneumoniae 
ATCC 6303 (aE104G and aD171F) and S. pneumoniae ATCC 49619 (aL99I and aE104G), 
52 changes in 1174/99, but no changes in 1162/99 (Fig. 2B). 
Chromosomal organization of the atp operon region. The virtual identity of the 
atpC and atpA sequences of S. mitis 1162/99 and S. pneumoniae led to the hypothesis that S. 
mitis 1162/99 have acquired this genome region from S. pneumoniae via horizontal transfer. 
To test this hypothesis,  the chromosomal region located 5’ of atpC was sequenced using 
chromosomal DNAs from the various strains, and oligonucleotides corresponding to the 
complementary strand of the primer coding for AtpC residues 11-18 (atpc18RSpn, 
atpc18RSmi or atpc18RSor). The comparisons of these sequences showed the presence in 
SmiT, SorT  and in the 1162/99 and 1174/97 isolates of a gene with high similarity (>87%) to 
spr1284 of S. pneumoniae R6 (16), or sp1429 of S. pneumoniae TIGR4 (39), encoding a 
putative peptidase. The spr1284 gene was contiguous to atpC in VS strains but is located in 
the R6 genome at 68,630 bp upstream atpC, and at 73,606 bp in the TIGR4 genome. Given 
the high similarity among the sequences of spr1284 of S. pneumoniae R6 and of the VS, an 
oligonucleotide (pepti101) was designed based on the spr1284 R6 sequence. Confirmation of 
the spr1284-atpCA gene organization in VS was obtained by PCR experiments. 
Amplifications with oligonucleotide pepti101, located in spr1284, and two oligonucleotides 
located either at atpC (atpC18RSmi) or atpB (atpB56 Fig. 3A) rendered DNA fragments of 
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1.4 and 2.4 kb, respectively, in SmiT, S. mitis 1162/99, and S. mitis 1174/97. Amplification of 
SorT with oligonucleotides pepti101 and atpC18RSor yielded a 1.6-kb fragment instead the 
1.4-kb fragment observed in SmiT, as expected from the larger size of the spr1284-atpC 
intergenic region of SorT, but no amplification with the pair peti101 and atpB56 was 
observed, probably due to low similarity between S. pneumoniae R6 and SorT at the atpB 
sequence. On the other hand, no amplification was observed in S. pneumoniae R6 with 
pepti101 and either atpC18RSpn or atpB56. However, PCR amplifications with an 
oligonucleotide located into IS1239 (upatp3), and atpC18RSpn yielded a 0.6 kb fragment in 
R6, and none in the VS (data not shown). The PCR products resulting from these 
amplifications were sequenced with the same oligonucleotides used for the amplifications as 
well as with internal primers. A comparison of the sequences of S. pneumoniae R6 and S. 
mitis 1162/99 showed almost complete identity in a 50-nt region located 5’ of atpC (positions 
1 to 50 of the sequence of Fig. 3B) that includes the 10 region of the atp promoter . From 
position 50 to 115, the sequence of S. mitis 1162/99 showed higher identity with SmiT 
(93.8%) that with S. pneumoniae R6 (78.5%). In addition, the size of the spr1284-atpC 
intergenic region in SorT DNA was 242260 nt longer than those of the S. mitis clinical 
isolates and SmiT (data not shown).  
An additional testing of the genetic structure of the atpC upstream chromosomal 
region in S. pneumoniae and VS was carried out by Southern blot hybridization using two 
probes derived from S. pneumoniae R6, one coding for Spr1284 amino acid residue positions 
101 to 413 (spr1284 probe) and another encoding AtpC and the first 113 residues of AtpA 
(atpCA probe).  The spr1284 probe, hybridized with the DNAs of all strains tested, indicating 
a high sequence similarity among spr1284 genes  (Fig. 3C). However, the atpCA probe 
hybridized only with S. pneumoniae R6 and S. mitis 1162/97 DNAs, as was expected from the 
low similarities among the sequences of the atpCA genes of S. pneumoniae R6 and those of 
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the rest of the VS strains (Fig. 2A). Hybridization of the spr1284 probe with S. pneumoniae 
R6 DNA showed two bands of 4.7 and 4.2-kb (NheI + HindIII) and a single band of 6.5-kb 
(NheI + EcoRV), whereas hybridization with the atpCA probe was at bands of 1.1-kb (NheI 
+HindIII ) and 2.9-kb (NheI +EcoRV), suggesting that spr1284 and atpCA were located at 
different chromosomal positions, accordingly with the restriction map for those enzymes in 
the R6 genome. However, hybridization of the spr1284 probe or the atpCA probe with S. mitis 
1162/99 showed bands of identical sizes (11-kb for NheI +HindIII and 5.2-kb for NheI + 
EcoRV digestions, Fig. 3C), indicating that spr1284 was located near to atpC and atpA in the 
S. mitis 1162/99 chromosome. 
 
DISCUSSION 
 Natural genetic transformation is essential for the genetic plasticity of S. pneumoniae 
(7). Interspecies recombination events between S. pneumoniae and the genetically related VS 
S. oralis and S. mitis have been described for the penicillin-binding-protein encoding genes 
(13, 37) and the fluoroquinolone target genes (4, 11). In these cases, interchanges have been 
detected in the presence of intense selective pressure, but this does not imply that other 
interchanges, both inter- and intraspecific, in genes not involved in antimicrobial resistance, 
are being occurring, as is the case for the genes encoding the capsular types (8), the comCDE 
loci required for competence (14) and for the genes of the F0 complex of the F0F1 H
+ ATPase 
of S. mitis 1162/99 showed in this work. A comparison of the chromosomal organization of 
the atp operon regions in S. pneumoniae, VS strains and S. mitis OptS strains (Fig. 2), together 
with that of the nucleotide sequences of the atpC-atpA-atpB regions, strongly suggest a 
recombinational origin for strain 1162/99. That recombination resulted in the acquisition of a 
region of about 1.3 kb that includes the complete atpC and atpA genes, and of 300-bp of atpB 
from S. pneumoniae. That interchange is responsible for the OptS phenotype of  S. mitis 
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1162/99 (Table 1) since the F0 (c, a, and b subunits) complex of the F0F1 H
+ -ATPase is 
responsible for that phenotype. Although the mutations conferring OptR map in atpC and atpA 
(9, 24, 28, 31), it is well know that the b-subunit is required for H+ translocation (36). The 
structure of the Escherichia coli subunit-b dimer is that of a single 33-amino acid residues 
transmembrane helix at its N-terminal region than interacts with F0 subunit-a and a 123-
residue-long cytoplasmic domain that binds to the -subunit and to one of the -subunits of F1 
(2, 15, 34). This structure is shared by the b-subunits of S. pneumoniae, SmiT, SorT, S. mitis 
1162/99 and S. mitis 1174/97 (data not shown). The N-terminal part of atpB of pneumococcal 
origin that is present in S. mitis 1162/99 includes the coding region of the first 100-amino acid 
residues of the b-subunit in which the transmembrane helix (residues 6 to 26) that interacts 
with the a-subunit is located. The same occurred in an OptR recombinant laboratory strain (S. 
pneumoniae M222) that we constructed by genetic transformation of S. pneumoniae R6 with 
DNA from SorT (9). Comparisons of the atp sequences of these strains and that of  S. mitis 
1162/99 showed that in the interchanges yielding the OptR S. pneumoniae strain M222 and the 
OptS S. mitis 1162/99 isolate, the same region of the atp operon was involved: the complete 
atpC and atpA genes, and 300-bp of the 5'-end of atpB. These results suggest that the 
organization of a functional F0F1 ATPase in both recombinant strains requires a b-subunit 
with a N-terminus compatible with the a-subunit and of a C-terminus compatible with the -
subunit. In this way, in S. mitis 1162/99, the N-terminus of the b-, a- and c-subunits are of 
pneumococcal origin, whereas the C-terminus of the b- and -subunits are of VS origin. 
Likewise, S. pneumoniae M222 had c-, a- and the 5'-end of b-subunits from SorT, whereas the 
-subunit (and the rest of F1 subunits) came from S. pneumoniae R6. The simultaneous 
interchange of the c- and a-subunits seems to be also a requisite for proper functioning of the 
F0 complex. The 5´ point of recombination in S. mitis 1162/99 would be at a 31-bp sequence 
located upstream atpC that is identical in S. pneumoniae and in all VS strains studied, with the 
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exception of a single change in S. pneumoniae strains (Fig. 3B). The 3´ point of 
recombination in both S. mitis 1162/99 and S. pneumoniae M222 would be at a 20-bp 
sequence in atpB that is almost identical in S. pneumoniae and in the VS strains studied (Fig. 
3B ). The sizes of these recombination regions are close to the minimal efficient processing 
segment for recombination in S. pneumoniae that is of about 30-bp (17). 
On the other hand, the intermediate OptS isolate 1174/97 has an atpCA sequence 
compatible with a VS species, and had several amino acid changes in their c- and a-subunits 
when compared with S. pneumoniae, SmiT and SorT (Fig. 2B). Among the amino acid 
residues of the c- and a-subunits know to be involved in the OptR/OptS phenotype of S. 
pneumoniae (9, 24, 28, 31), there is only one residue that changed in SorT and SmiT but that is 
conserved in S. pneumoniae and S. mitis 1174/97: residue L186 of the a-subunit. A L186P 
change has been shown to be responsible for the intermediate OptS phenotype (MIC of 6 
g/ml, the same observed for strain 1174/97) of the S. pneumoniae MJM21 strain (24). That 
residue is located in -helix 5 of the a-subunit that includes residues 172 to 191 (24). Identity 
was observed among S. pneumoniae and S. mitis 1174/97 in that -helix 5 while several 
changes are present in SmiT and in SorT with respect S. pneumoniae. The identity found 
between -helix 5 of S. mitis 1174/97 and S. pneumoniae could be responsible for the 
intermediate OptS phenotype of S. mitis 1174/97. 
 Currently most clinical laboratories depend on the OPT susceptibility test for S. 
pneumoniae identification. Accordingly, the two OptS VS described in this work, the fully 
OptS and the intermediate OptS VS, were identified as S. pneumoniae by the clinical 
laboratories that had sent them to the reference laboratory. Since misidentification of OptS VS 
as S. pneumoniae may have significant implications for the management of patients, to 
perform at least two tests for the identification of S. pneumoniae, i.e., OPT susceptibility and 
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TABLE 1. Oligonucleotides used in this work 
 
Name Sequence (5’-3’)a Nucleotide (amino acid) positionsb 
atp660 ggtcggaaTTCCAATAGCGGTTAAAAGTTG 83 to 62 of atpC  
antDOWN  TCATGAGTCTTCTCCTCTCGC Complementary to 853 to 873 of ant (285ARGEDS290) 
antUP  GCTGTCGCCATGTCTGGTTCACG 76 to 98 of ant (26AVAMSGSR33) 
atpA 107R  GCGGTTGGCGAACTCCACCAG Complementary to 318 to 338 of atpA (107WWSSPTA113) 
atpB56  GACGGGCTTCTTCAGCTCTGTC Complementary to 169 to 147 of atpB ( 50DRAEEAR56) 
atpc18RSmi  CCAAGAGACACACCCATACAGGC Complementary to 31 to 53 of atpC (11ACMGVSVG18 )c 
atpc18RSor GCAAGAGATACACCCATACAGGC Complementary to 31 to 53 of atpC (11ACMGVSVG18 )d 
atpc18RSpn CCGACAGATACGCCCATACAGGC Complementary o 31 to 53 of atpC (11ACMGVSVG18 ) 
atpWO gcgcatgcTTAAAGGAGAATTTGTTATGAA 15 to 5 of atpC (1MN2) 
pepti101  GCAGTTATCGTATCTGACCCAGCC  304 to 327 of spr1284 (102AVIVSDPA109) 
pepti413R CGAACCATGTCTCCTGATTGAACGGG  Complementary to 1213 to 1238 of spr1284 (405PVQSGDMVR413) 
UPatp3 tcggaagcttAGGAAAAGCGCTTAAGAACA 651 to631 of atpC 
16SDNAF1 GAGTTGCGAACGGGTGAGT 86 to 104 of 16S rRNA 
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16SDNAF2 GTGGCGAAAGCGGCTCTCTGG 719 to 739 of 16S rRNA 
16SDNAR1 AGCGATTCCGACTTCAT Complementary to 1326 to 1342 of 16S rRNA 
16sDNAR2 CCAGAGAGCCGCTTTCGCCAC Complementary to 719 to 739 of 16S rRNA 
 
a The 5’ end of upatp3 and atpWO contained a sequence including a HindIII or EcoRI restriction sites, respectively, which are shown underlined. 
Lower case letters indicate bases not present in the nucleotide sequence of S. pneumoniae R6. 
b The nucleotide and amino acid numbering refers to the numbering for the genes and proteins of the S. pneumoniae R6 sequence, with the first 
nucleotide or amino acid being at position 1. 
c The nucleotide and amino acid numbering refers to the numbering for atpC gene and protein of the S. mitis NCTC 12261T, with the first 
nucleotide or amino acid being at position 1. 
d The nucleotide and amino acid numbering refers to the numbering for atpC gene and protein of the S. oralis NCTC 11427T, with the first 
nucleotide or amino acid being at position 1.
 22 
 
TABLE 2 . Susceptibilities of S. pneumoniae and VS strains to amino alcohol antimalarials  
 
Strain MIC (g/ml)a  
 OPT QIN  MFL 
S. pneumoniae R6 1.5 50 0.15 
S. pneumoniae ATCC 6303 0.75 25 0.15 
S. pneumoniae ATCC 49619 1.5 50 0.15 
S. mitis NCTC 12261  96 800 40 
S. oralis ATCC 10557 48 400 40 
S. oralis NCTC 11427 48 400 20 
S. mitis 1162/99 0.75 50 0.30 
S. mitis 1174/97 6 800 10 
 
a Susceptibility categorizations for OPT, QIN and MFL: resistant, MIC 6 g/ml, MICs 
200 g/ml, and MICs 0.62 g/ml, respectively; intermediate, MICs 3 to 6 g/ml, MICs 100 to 
200 g/ml, and MICs 0.3 to 0.6 g/ml, respectively; susceptible, MIC 1.5 g/ml, MIC 50 
g/ml, and MIC 1.25 g/ml, respectively. 
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FIG. 1. Identification of VS by hybridization with a specific DNA probe (A) and identification as 
S. mitis by sequencing sodA (B). (A) Chromosomal DNAs from S. pneumoniae R6 (SPN), S. 
mitis NCTC 12261T (SMI), S. oralis NCTC 11427T (SOR), and isolates 1162/99 and 1174/97 
were cleaved with NheI plus HindII (lanes NH) or NheI plus EcoRV (lanes NE), and the 
fragments were separated in 1% agarose gels. Mw, biotinylated DNA ladder. The gel was blotted 
and the blot was probed with a 798-bp biotinylated fragment containing most of the ant gene. (B) 
UPGMA tree of 365-bp sodA fragments. (B) The sequences of strains 1162/99 and 1174/97 were 
compared with that of the type strains of S. mitis (NCTC 12261), S. pneumoniae (NCTC 7465), S. 
oralis (NCTC 11427), S. parasanguis (ATCC 15912), S. gordonii (ATCC 10558), and S. sanguis 
(ATCC 10556). Phylogenetic analyses were conducted with the MEGA program (version 2.1) by 
the UPGMA method. Only bootstrap confidence intervals exceeding 90% are shown.  
FIG. 2. Nucleotide sequence variations in the atpC and atpA genes (A) and comparisons of the 
amino acid sequences and secondary structures of the c and a subunits (B) of S. pneumoniae and 
VS strains. (A) The nucleotides present at each polymorphic site are shown for strain R6 , but for 
the other strains, only nucleotides that differ from those in R6 are shown. Codon numbers are 
indicated vertically above the sequences. Positions 1, 2, and 3 refer to the first, second, and third 
nucleotides in the codon, respectively. Triangles indicate gaps. (B) The predicted -helices (H1 
to H6) are shown above the sequence of SPN R6. Residues mutated in OptR strains (24) are 
shown in boldface and double underlined. Residues involved in proton translocation are boxed. S. 
pneumoniae R6 (SPN R6, accession number Z25851), S. pneumoniae ATCC 6303 (SPN 6303), 
S. pneumoniae ATCC 49619 (SPN 49619), VS 1162/99 (1162), VS 1174/97 (1174), S. mitis 
NCTC 12261 (SMI), and S. oralis NCTC 11427 (SOR, accession numbers Z26852 and Z26853). 
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FIG 3. Genetic structure of the atp region of S. pneumoniae and VS (A), Nucleotide sequence of 
the region surrounding the recombination point in strain 1162/99 (B), and Southern blot 
hybridizations with two different probes (C ). (B) The putative recombination regions are boxed. 
(C) Symbols are as in Fig. 1, except that H means digestion with NheI plus HindII and E means 
digestion with NheI plus EcoRV. The gel was blotted and the blot probed with the spr1284 probe. 
After stripping, the blot was reprobed with the atpCA probe. 
 
